Intermede Investment Partners’s Medtronic MDT Stock Holding History

Intermede Investment Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-648,808	Closed	-$52M	–	28
2018 Q1	$52M	Sell	648,808 -58,076	-8%	-$4.79M	4.47%	11
2017 Q4	$57.1M	Buy	706,884 +35,350	+5%	+$2.83M	4.85%	9
2017 Q3	$52.2M	Buy	671,534 +51,029	+8%	+$4.24M	4.78%	9
2017 Q2	$55.1M	Buy	620,505 +1,931	+0.3%	+$163K	5.33%	6
2017 Q1	$49.8M	Buy	618,574 +132,837	+27%	+$10.4M	5.21%	6
2016 Q4	$34.6M	Sell	485,737 -12,980	-3%	-$1.02M	4.05%	10
2016 Q3	$43.1M	Buy	498,717 +6,054	+1%	+$528K	4.77%	6
2016 Q2	$42.7M	Buy	492,663 +9,574	+2%	+$774K	4.96%	5
2016 Q1	$36.2M	Buy	483,089 +138,857	+40%	+$10.5M	4.36%	9
2015 Q4	$26.5M	Buy	+344,232	New	+$25.9M	4.48%	6

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Intermede Investment Partners's MDT Position: Q2 2018 in Review

Intermede Investment Partners sold out of Medtronic (MDT) in Q2 2018, closing a stake of 648,808 shares — an estimated $52M sold.

Intermede Investment Partners first reported a position in MDT in Q4 2015 and held it in 10 quarters. The position peaked at $57.1M in Q4 2017. 1,409 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

Intermede Investment Partners reported no remaining Medtronic position as of Q2 2018 after selling out during the quarter.
Intermede Investment Partners sold 648,808 Medtronic shares in Q2 2018, an estimated $52M.
Intermede Investment Partners first reported a position in Medtronic in Q4 2015 and held it in 10 quarters.
Intermede Investment Partners's Medtronic position peaked at $57.1M in Q4 2017.
1,409 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on Intermede Investment Partners's 13F filing for Q2 2018, filed 8 Aug 2018.